Introduction n
Routinee histological examination of clinically unsuspected mastectomy scars thatt are excised during secondary corrective surgery is considered good practice 11 as these scars may contain metastases caused by spilling of the tumor duringg the initially curative mastectomy. 24 The same may hold true for scars afterr prophylactically performed mastectomies because de novo invasive or non-invasivee tumors may have developed in any normal glandular tissue that wass left or spilled during initial surgery. 56 Still, the microscopic detection of a metastasiss in clinically unsuspected mastectomy scars is rare and, 17 in the currentt era of cost-controlled and evidence-based medicine, optimal use of histologicall services is required. Therefore, the occurrence rate of metastases inn such scars needs to be established to assess the possible benefit of their routinee histological examination. Too date, only Soldin et al. 7 tried to establish this rate but they admitted that the numberr of scars they included in their study (n = 48) was too small to yield any statisticall significance to their study. Furthermore, over half of the patients in theirr limited series had their scar excised more than 3 years after the excision of thee primary cancer, 7 while up to 90 percent of local recurrences occur within thesee 3 years. 811 Hence, we assessed the results of routine histological examinationn of 728 clinically unsuspected scars, 503 (or 70%) of which were excised withinn the first 3 postmastectomy years.
Materialss and Methods

Scars s
Alll clinically unsuspected scars excised during secondary breast reconstruction orr scar correction after mastectomy or breast conservation therapy (BCT) and submittedd by the plastic surgeons of the Netherlands Cancer Institute for histologicall examination from January of 1994 through May of 2004 were traced.. This was done by cross-linkage of a database containing all plastic surgicall data on breast surgery, and a database containing the pathology reportss that featured the keywords scar, thorax, breast, or mamma. The databasess where linked using Microsoft Access (MS-Office 2000 Professional, Microsoftt Corporation, Redmond, Washington). This way, 728 scars could be includedd in this retrospective analysis.
Histologicall examination
Thee 728 clinically unsuspected scars had been examined for metastases followingg initial curative therapy, or for de novo invasive or non-invasive tumors subsequentt to prophylactic treatment. Each specimen had been macroscopicallyy examined for evidence of tumor and multiple representative slides had beenn made and stained by hematoxylin and eosin for microscopic examination. Occurrencee of tumor or normal glandular spilling had been noted in the pathologyy reports.
Recordedd and analyzed data Thee date, indication (curative or prophylactic), and side (left or right) of initial mastectomyy or BCT were entered in a computer database created in Microsoft Excell and Microsoft Access (MS-Office 2000 Professional, Microsoft Corporation,, Redmond, Washington), along with the age of the patient at the time of initiall surgery and the data on any adjuvant therapy. The dates of subsequent secondaryy surgery were entered to calculate the time interval since initial breast surgery.. Furthermore, it was recorded whether or not recurrence or metastasis off the tumor outside the scar had occurred prior to secondary surgery. The histologicall findings of all 728 scars, the period of follow-up after secondary surgeryy and, finally, any local recurrence or distant metastasis during that periodd were also recorded. Notee that curative mastectomy was combined with contralateral breast conservation therapy in 5 patients so the totall number of curatively treated patients appears to amount to 366 rather than 361. Because, furthermore, unilaterall curative mastectomy or BCT was combined with contralateral prophylactic mastectomy in 45 other patients,, the sum of curatively and prophylactically treated patients amounts to 474 rather than 424. ** Curative mastectomies included radical, modified radical, and skin sparing mastectomies ## Prophylactic mastectomies included modified radical and skin sparing mastectomies Notee that curative mastectomy was combined with contralateral breast conservation therapy in 5 patients so the totall number of curatively treated patients appears to amount to 366 rather than 361. Because, furthermore, unilaterall curative mastectomy or BCT was combined with contralateral prophylactic mastectomy in 45 other patients,, the sum of curatively and prophylactically treated patients amounts to 474 rather than 424 DCC IS / LCIS: ductal carcinoma in situ / lobular carcinoma in situ whoo initially underwent curative breast surgery, invasive breast cancer had beenn present, whereas non-invasive ductal or lobular tumors (DCIS or LCIS) hadd been found in the 110 remaining specimen of these curatively treated breastss ( Table 2 ). The pathology reports on all 395 specimen mentioned adequatee tumor-free margins.
Results s
Meann follow-up of the 361 curatively treated patients to date was 7.3 years (range,, 8 months -32 years). Twenty-three of these patients had a local recurrencee and 41 patients had distant metastases during this follow-up period. Nine off the 23 local recurrences occurred before secondary breast surgery and scar examinationn had been performed but none occurred within the mastectomy scar. . Inn none of the 151 specimens of the 108 patients who initially underwent prophylacticc mastectomy, invasive or non-invasive tumors had been found. Mean follow-upp after initial surgery of these patients to date was 4.6 years (range, 11.33 months -25.7 years). None of these patients developed a de novo breast tumorr during follow-up.
Dataa on secondary breast surgery SubsequentSubsequent to their initial treatment, 214 of the 424 patients had their breast scarr excised and histologically examined only once, whereas the remaining 210 patientss had multiple scars excised and examined or had their scars excised on multiplee occasions (Table 3) . As held true for initial breast surgery, the scars weree equally divided between the left and right breast. Of all 728 scars, 542 weree excised following curative breast surgery whereas the remaining 186 were 
5
Notee that 214 of the 424 patients had their breast scar excised and histologically examined only once, whereas thee remaining 210 patients had multiple scars excised and examined or had their scars excised on multiple occasions. . Notee that the total number of patients amounts to 469 rather than 424 because 45 patients underwent unilateral curativee treatment combined with contralateral prophylactic treatment.
excisedd subsequent to prophylactic mastectomy (Tables 1 and 2 ). The mean timee interval between initial breast surgery and resection and histological examinationn of the scars was 38.5 months (range, 34 days -31.4 years) ( Table  4) . . Noo evidence of metastatic or de novo tumor was found in any of the 728 scars butt residual glandular tissue was found in 11 scars. Because no scar metastasess or de novo tumors were observed during the entire post-mastectomy followupp of 6.9 years, we conclude that the risk of tumor in clinically unsuspected scarss in our series is less than 1 in 728. Because no scar tumors were found, moreover,, we were unable to objectify any possible relation between the indicationn of initial surgery, the type of initial tumor and treatment, possible local recurrencee or distant metastasis, and occurrence of microscopic scar metastasis.
Discussion n
Timee interval, frequency and site of local recurrence following initially curativee surgery Locall recurrence following mastectomy or BCT for malignant breast disease occurss in 5 to 19 percent of the patients. 1116 Local recurrence is related to tumor stagee and time lapse since treatment of the primary tumor.' 617 There are no significantt differences in local recurrence and overall survival rates between modifiedd radical mastectomy and BCT, 9 or between modified radical mastectomyy and skin sparing mastectomy. 1118 However, there is a significant differencee between mastectomy and BCT in the disease free time interval as 80 to 900 percent of local recurrences occurs within three years after modified radical mastectomy, 81011199 whereas only 30 to 40 percent occurs within 5 years after BCT. 10111 In general, local recurrence may cause distant metastasis but may, equally,, indicate such metastasis. 216 Distant metastases often appear simultaneouslyy with, or shortly after, the local recurrence and, because they feature a poorr prognosis, early detection of the recurrence may benefit the patient. 4 Their patient hadd been maximally treated for a locally advanced cancer the year before secondaryy breast reconstruction. Even though preoperative consultation had nott revealed any signs of local recurrrence, routine histological examination of thee mastectomy scar revealed the presence of carcinoma. 4 Nonee of the 23 local recurrences observed in our series to date involved the mastectomyy scar. Likewise, no malignancy was found in any of the scars that weree examined within 3 years after surgery in 240 of the 361 curatively treated patientss (67%), while up to 90 percent of local recurrences might have been expectedd to occur within that period of time. Still, we do not know how many patientss possibly were not referred by the surgical oncologist for secondary breastt reconstruction or scar correction as a consequence of scar metastasis andd this may present a potential limitation of our retrospective analysis. Moreover,, the Netherlands Cancer Institute is a center of tertiary referral and it is not clearr how many patients had their mastectomy or BCT scar secondarily excised andd examined elsewhere after having had primary treatment in our institute.
Timee interval, frequency and site of de novo tumors following initially prophylacticc surgery
Followingg bilateral prophylactic mastectomy, Hartmann et al. 5 and Rebbeck et al. 66 found de novo invasive or non-invasive breast tumors to occur of 1.1 to 1.9
percentt of women with a moderate to high risk of such cancers. Most of these dee novo tumors only occur after a median of 6 years (range, 2-25 years) and, moree often than not, feature a favorable prognosis. 56 So far, none of the breast cancerss observed after prophylactic mastectomy was reported to occur in the mastectomyy scar. 5 Inn our study, we did not observe de novo tumor growth in any of our 108 prophylacticallyy operated patients (186 breasts). Still, the time interval between prophylacticc mastectomy and scar examination was less than 3 years in 97 of thee 108 patients (Table 4 ) and de novo breast tumors usually present six years afterr prophylactic mastectomy. 56 Therefore, we can not rule out any cases to stilll present among our patients.
Thee benefits of routine histological examination of unsuspected mastectomyy scars
Inn all, early detection of local recurrence after curative breast surgery is of great importancee and the question is if routine histological examination of secondarily excisedd unsuspected mastectomy scars enhances such early detection. To date,, only very few local recurrences have reportedly been found in macroscopicallyy unsuspected scars, 14 but it seems accurate to recommend to routinelyy perform histological examination as such examination may most accuratelyy detect early local recurrence within an unsuspected scar. Still, only a very small,, so-called representative part of the scar is being examined in such cases andd early malignancy in any other part of the specimen may easily be overlooked.. Moreover, additional native breast skin that is often removed during autologouss secondary breast reconstruction is usually not examined routinely. Ass we did not observe any macroscopic or microscopic scar malignancy during long-termm follow-up and regardless of primary tumor stage and time lapse since primaryy diagnosis, we conclude that the routine submission of these scars for histologicall examination did not benefit the early detection of such malignancy inn our patients over the last 10 years. Given the extremely low yield of such submissionn and the poor natural prognosis of local recurrences per se, the medico-legall consequences of refraining to routinely submit unsuspected scars aree presumably non-existing in the Netherlands. The pathologist may very well bee the only one to benefit from such examination even though, in the Netherlands,, only 50 Euro (or US$ 65) may be charged per scar. AA more secure and less elaborate method of early detection of superficial local recurrencess in the mastectomy scar was mentioned in 1995, when Ciatto observedd that palpation currently is accepted to be highly sensitive for such detection. 255 The occurrence of tiny painless nodules is the most common form off presentation of local recurrence and, 13 accordingly, Ciatto advised regular palpationn as the screening test of choice for local recurrences and recommendedd the addition of ultrasonography and aspiration cytology to improve the diagnosticc accuracy, only in questionable cases. 25 
Conclusion n
Basedd on their limited study, Soldin et al. 7 surmised that histological examinationn of breast scar at the time of secondary reconstruction provides no oncologicall benefit for patients in whom comprehensive clinical examination or radiologicall imaging after BCT had not already detected local recurrence. Because wee found no evidence of tumor in any of the 728 scars we, more convincingly, supportt and extend their conclusion in that routine submitting of clinically unsuspectedd scars excised at the time of breast reconstruction or scar correctionn after prophylactic or curative breast surgery did not benefit our patients.
